Vous avez cherché: alpha lipoic acid (ala) (Anglais - Slovène)

alpha-lipoic acid 300,
alfa-lipoična kislina 300,

400 iu vitamin e, approximately 200 mg linoleic acid, 110 mg eicosapentaenoic acid (epa), 210 mg alpha linolenic acid (ala) and 80 mg docosahexaenoic acid (dha) per day).
400 i.e. vitamina e, približno 200 mg linolne kisline, 110 mg eikozapentaenojske kisline (epa), 210 mg alfa-linolenske kisline (ala) in 80 mg dokozaheksaenojske kisline (dha) na dan).

based on observations of decreased essential fatty acid and vitamin e levels in clinical trials, patients should take daily dietary supplements that provide 400 iu vitamin e and approximately 200 mg linoleic acid, 110 mg eicosapentaenoic acid (epa), 210 mg alpha linolenic acid (ala) and 80 mg docosahexaenoic acid (dha) per day, throughout treatment with lojuxta.
ker so v kliničnih preskušanjih opazili znižanje ravni esencialnih maščobnih kislin in vitamina e, morajo bolniki med celotnim zdravljenjem z zdravilom lojuxta jemati dnevne prehranske dodatke, ki zagotavljajo 400 i.e. vitamina e in približno 200 mg linolne kisline, 110 mg eikozapentaenojske kisline (epa), 210 mg alfa-linolenske kisline (ala) ter 80 mg dokozaheksaenojske kisline (dha) na dan.

in the phase 3 trial, patients were provided daily dietary supplements of vitamin e, linoleic acid, ala, epa and dha.
v preskušanju 3. faze so bolniki prejemali dnevne prehranske dodatke vitamina e, linolne kisline, ala, epa in dha.

following an application from unilever plc/nv submitted pursuant to article 14(1)(b) of regulation (ec) no 1924/2006, the authority was required to deliver an opinion on a health claim related to the effects of α-linolenic acid (ala) and linoleic acid (la) on growth and development of children (question no efsa-q-2008-079) [4].
družba unilever plc/nv je v skladu s členom 14(1)(b) uredbe (es) št. 1924/2006 predložila vlogo, agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z vplivi α-linolenske kisline (ala) in linolne kisline (la) na rast in razvoj otrok (vprašanje št. efsa-q-2008-079) [4].